Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Novartis image

Two Novartis drugs get first in class EU approvals

September 2, 2015 Research and Development, Sales and Marketing Novartis

The European Commission has approved Revolade for severe aplastic anaemia, and the combination of Tafinlar and Mekinist for patients with …
News
Xarelto

Bayer backs safety of Xarelto after real-world data study

September 2, 2015 Research and Development Bayer, ESC, European Society of Cardiology, Xarelto, anticoagulants, atrial fibrillation, real-word evidence, rivaroxaban

Around 96 in every 100 people treated with Bayer’s anticoagulant Xarelto do not experience any major bleeding, related side effects …
News
scales

Standardising the pharma benefit-risk assessment process

September 1, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, benefit-risk analysis, pharmacoepidemiology, pharmacovigilance

Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view …
Feature
mytrus_cartoon

NHS approves electronic consent technology in clinical trials

August 28, 2015 Medical Communications, Research and Development Mytrus, NHS, clinical trials, digital health technology, electronic informed consent

Clinical technology and services company Mytrus has announced that its software platform for electronic informed consent has received approval for …
News
boehringer_lilly

New Boehringer and Lilly type 2 diabetes treatment gets FDA nod

August 28, 2015 Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, Synjardy, type 2 diabetes

The FDA has approved Synjardy, from Boehringer Ingelheim and Eli Lilly, for the treatment of adults with type 2 diabetes. …
News

FDA approves Amgen’s cholesterol lowering drug

August 28, 2015 Medical Communications, Research and Development Amgen, FDA, Repatha, evolocumab

The FDA has endorsed Amgen’s cholesterol-lowering medication, Repatha, for the use in patients with high cholesterol. It follows Amgen’s successful …
News
ESC congress sign

NHS looks to ESC for next-gen heart drug data

August 28, 2015 Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …
News

Novo Nordisk to buy two pharma research companies

August 27, 2015 Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …
News
md_anderson_cancer_center

Immatics and MD Anderson launch new company to develop ACR therapies

August 27, 2015 Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda

Immatics Biotechnologies and The University of Texas MD Anderson Cancer Center (MDACC) have together launched a new company focusing on …
News
alimta

Lilly defeats Teva in US court over Alimta patent

August 26, 2015 Research and Development, Sales and Marketing Alimta, Eli Lilly, Teva Pharmaceutical, lung cancer

Eli Lilly has won a case in a US federal court, in a battle over Teva’s attempt to create a …
News
artist's impression

Novo Nordisk plans $2bn expansion of production facilities

August 26, 2015 Manufacturing and Production, Research and Development Novo Nordisk, manufacturing

Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …
News
crossroads

After the legal case – where next for pharma industry transparency?

August 26, 2015 Research and Development clinical trial transparency, clinical trials, health research authority, transparency

Even in an industry as litigious as pharma can sometimes be, the recent legal drama that has played out in …
Feature
novonordiskhq

Novo Nordisk abandons Victoza submission after mixed T1D results

August 26, 2015 Research and Development Novo Nordisk, Victoza, diabetes, insulin

Novo Nordisk has been forced to scrap plans to expand its licence for Victoza to include adults with type 1 …
News
Ebola virus

Researchers hopeful experimental antiviral treatment stops Ebola

August 26, 2015 Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp

An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …
News
Abasaglar

Lilly and Boehringer launch biosimilar insulin in the UK

August 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly

Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025